Speech treatment in Parkinson's disease: Randomized controlled trial (RCT)

BACKGROUND: As many as 89% of people with Parkinson's disease (PD) develop speech disorders. OBJECTIVES: This randomized controlled trial evaluated two speech treatments for PD matched in intensive dosage and high‐effort mode of delivery, differing in subsystem target: voice (respiratory‐laryng...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramig, Lorraine, Halpern, Angela, Spielman, Jennifer, Fox, Cynthia, Freeman, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261685/
https://www.ncbi.nlm.nih.gov/pubmed/30264896
http://dx.doi.org/10.1002/mds.27460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6261685/
https://www.ncbi.nlm.nih.gov/pubmed/30264896
http://dx.doi.org/10.1002/mds.27460

Ejemplares similares